COVID-19 In-vitro Diagnostic Test and Androgen Receptor Gene Expression

Withdrawn before enrolling

Conditions studied: Covid19, Androgen Receptor Gene Overexpression

In brief

This research study will evaluate the association of Androgen Receptor (AR) gene expression and COVID-19 disease severity and mortality. The research procedure involves collection of a single saliva sample which will be mailed to the participants by the study team. This saliva will be used in a COVID-19 Androgen Sensitivity Test (CoVAST) which will detect AR gene expression. Eligible participants are males, at least 18 years or older, and have tested positive for COVID-19.

Key facts

Study ID

NCT04530500

Run by

University of California, Irvine

People needed

0

Starts

2020-08-13

Expected to finish

2023-12-01

Last updated by the study team

2024-05-08

Who can join

Age: 18 and older, up to 90. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Male over the age of 18
• Laboratory confirmed SARS-CoV-2 infection
• Able to give verbal informed consent

You may not qualify if…

• Unable to give informed consent
• Diagnosed with an additional respiratory co-infection
• XXY males

Where it is running

• Applied Biology, Inc — Irvine, California, United States
• University of California, Irvine - Dermatology Clinical Research — Irvine, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.